The risk of malignancy in patients with secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis

被引：1
|
作者：
van de Kerkhof, P. C. M. [1 ]
机构：
[1] Radboud Univ Nijmegen, Dept Dermatol, Med Ctr, Nijmegen, Netherlands
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2021年 / 185卷 / 05期
关键词：
D O I：
10.1111/bjd.20624
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：879 / 879
页数：1
相关论文
共 50 条
  • [1] Persistence of secukinumab in patients with psoriasis, psoriatic arthritis, and ankylosing spondylitis
    Conesa-Nicolas, Elena
    Henar Garcia-Lagunar, Maria
    Nunez-Bracamonte, Sara
    Sergia Garcia-Simon, Maria
    Carmen Mira-Sirvent, Maria
    [J]. FARMACIA HOSPITALARIA, 2021, 45 (01) : 16 - 21
  • [2] The risk of malignancy in patients with secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis: analysis of clinical trial and postmarketing surveillance data with up to five years of follow-up
    Lebwohl, M.
    Deodhar, A.
    Griffiths, C. E. M.
    Menter, M. A.
    Poddubnyy, D.
    Bao, W.
    Jehl, V.
    Marfo, K.
    Primatesta, P.
    Shete, A.
    Trivedi, V.
    Mease, P. J.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (05) : 935 - 944
  • [3] Secukinumab for ankylosing spondylitis and psoriatic arthritis
    Lubrano, Ennio
    Perrotta, Fabio Massimo
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 1587 - 1592
  • [4] Association of Secukinumab Treatment With Tuberculosis Reactivation in Patients With Psoriasis, Psoriatic Arthritis, or Ankylosing Spondylitis
    Elewski, Boni E.
    Baddley, John W.
    Deodhar, Atul A.
    Magrey, Marina
    Rich, Phoebe A.
    Soriano, Enrique R.
    Soung, Jennifer
    Bao, Weibin
    Keininger, Dorothy
    Marfo, Kwaku
    Patekar, Manmath
    Sharma, Abhishek
    Shete, Abhijit
    Lebwohl, Mark Gabriel
    [J]. JAMA DERMATOLOGY, 2021, 157 (01) : 43 - 51
  • [5] No Increased Risk of Inflammatory Bowel Disease Among Secukinumab-Treated Patients with Moderate to Severe Psoriasis, Psoriatic Arthritis, or Ankylosing Spondylitis: Data from 14 Phase 2 and Phase 3 Clinical Studies
    Deodhar, Atul A.
    Schreiber, Stefan
    Gandhi, Kunal
    Fox, Todd
    Gaillez, Corine
    Karyekar, Chetan
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [6] NO INCREASED RISK OF INFLAMMATORY BOWEL DISEASE AMONG SECUKINUMAB-TREATED PATIENTS WITH MODERATE TO SEVERE PSORIASIS, PSORIATIC ARTHRITIS, OR ANKYLOSING SPONDYLITIS: DATA FROM 14 PHASE 2 AND PHASE 3 CLINICAL STUDIES
    Zochling, J.
    Deodhar, A.
    Schreiber, S.
    Gandhi, K.
    Fox, T.
    Gaillez, C.
    Karyekar, C.
    [J]. INTERNAL MEDICINE JOURNAL, 2017, 47 : 38 - 39
  • [7] The role of secukinumab in the treatment of psoriatic arthritis and ankylosing spondylitis
    Garcia-Montoya, Leticia
    Marzo-Ortega, Helena
    [J]. THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2018, 10 (09) : 169 - 180
  • [8] Predictors of Response in Secukinumab-treated Patients with Ankylosing Spondylitis: Logistic Regression and Machine Learning Analyses
    Miceli-Richard, Corinne
    Poddubnyy, Denis
    Deodhar, Atul
    Bao, Weibin
    Parman, Craig
    Porter, Brian
    Pournara, Effie
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [9] Secukinumab in pregnancy: outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database
    Warren, R. B.
    Reich, K.
    Langley, R. G.
    Strober, B.
    Gladman, D.
    Deodhar, A.
    Bachhuber, T.
    Bao, W.
    Altemeyer, E.
    Hussain, S.
    Safi, J., Jr.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (05) : 1205 - 1207
  • [10] SECUKINUMAB IN PREGNANCY: OUTCOMES IN PSORIASIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS FROM THE GLOBAL SAFETY DATABASE
    Warren, Richard
    Reich, Kristian
    Langley, Richard
    Strober, Bruce
    Gladman, Dafna
    Deodhar, Atul
    Bachhuber, Teresa
    Bao, Weibin
    Altemeyer, Evelyn
    Hussain, Samina
    Safi, Jorge
    [J]. ACTA DERMATO-VENEREOLOGICA, 2018, 98 : 11 - 11
12345